A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma

BACKGROUND: Ovarian cancer is the most fatal tumor of the female reproductive system and the fifth leading cause of cancer death among women in the USA. The prognosis is poor due to the lack of biomarkers for treatment options. RESULTS: The methylation array data of 551 patients with ovarian serous...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Wenna, Zhu, Liucun, Yu, Minghao, Zhu, Rui, Chen, Qihan, Wang, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240326/
https://www.ncbi.nlm.nih.gov/pubmed/30446011
http://dx.doi.org/10.1186/s13148-018-0574-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240326/
https://www.ncbi.nlm.nih.gov/pubmed/30446011
http://dx.doi.org/10.1186/s13148-018-0574-0

Ejemplares similares